Rune Midgard

country of citizenship: Norway

educated at: University of Bergen

occupation: researcher, physician

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 52

Date

Title

Authors

2020-03-26

High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018

Johannes Sverre Willumsen, Kjell-Morten Myhr, Rune Midgard, Jan Harald Aarseth
2020-06-23

Factors influencing employment after minor stroke and NSTEMI

Halvor Næss, Rune Midgard, Åse H Morsund, Sigrid B Sando, Egil Jonsbu
2019-04-01

Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study

Åse H Morsund, Rune Midgard, Halvor Næss, Sigrid B Sando, Egil Jonsbu
2019-10-01

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study

Elisabeth Gulowsen Celius, Øivind Torkildsen, Trond Riise, Kjell-Morten Myhr, Espen Benjaminsen, Rune Midgard, Jan Harald Aarseth
2019-07-15

The development of cognitive and emotional impairment after a minor stroke: A longitudinal study

Åse H Morsund, Halvor Næss, Rune Midgard, Sigrid B Sando, Egil Jonsbu
2019-10-01

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial

Johannes Roksund Hov, Thor Ueland, Trygve Holmøy, Rune Midgard, Kjell-Morten Myhr
2018-07-24

Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis

Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Rune Midgard, Stig Wergeland
2018-06-04

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients

Kjetil Bjornevik, Øivind Torkildsen, Trond Riise, Kjell-Morten Myhr, Trygve Holmøy, Rune Midgard, Stig Wergeland
2016-07-14

No association of tobacco use and disease activity in multiple sclerosis

Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Rune Midgard, Stig Wergeland
2016-05-05

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study

Kjetil Bjornevik, Trond Riise, Øivind Torkildsen, Kjell-Morten Myhr, Espen Benjaminsen, Elisabeth Gulowsen Celius, Rune Midgard
2016-08-23

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom

Trond Riise, Elisabeth Farbu, Kjell-Morten Myhr, Alberto Ascherio, Kjetil Bjornevik, Marianna Cortese, Rune Midgard
2016-03-21

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

Trond Riise, Øivind Torkildsen, Trygve Holmøy, Rune Midgard, Stig Wergeland, Kjell-Morten Myhr
2015-09-26

Body mass index influence interferon-beta treatment response in multiple sclerosis

Pål Aukrust, Thor Ueland, Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Annika E. Michelsen, Antonie G Beiske, Kristian S Bjerve, Harald Hovdal, Finn Lilleås, Rune Midgard, Stig Wergeland, Jūratė Šaltytė Benth, Søren Jacob Bakke
2015-02-11

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis

Pål Aukrust, Thor Ueland, Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Annika E. Michelsen, Antonie G Beiske, Kristian S Bjerve, Harald Hovdal, Finn Lilleås, Rune Midgard, Stig Wergeland, Jūratė Šaltytė Benth, Søren Jacob Bakke, Egil Røsjø
2015-06-02

WT1 and interferon-β-vitamin D association in MS: a longitudinal study

Øivind Torkildsen, Trygve Holmøy, Rune Midgard, Stig Wergeland, Kjell-Morten Myhr
2014-02-04

Month of birth and risk of multiple sclerosis: confounding and adjustments

Trond Riise, Trygve Holmøy, Kjell-Morten Myhr, Espen Benjaminsen, Øivind Torkildsen, Elisabeth Gulowsen Celius, Rune Midgard, Jan Harald Aarseth
2014-05-19

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Rune Midgard, Stig Wergeland
2014-03-24

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis

Pål Aukrust, Thor Ueland, Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Annika E. Michelsen, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, Antonie G Beiske, Kristian S Bjerve, Harald Hovdal, Finn Lilleås, Rune Midgard, Stig Wergeland, Egil Røsjø
2014-04-10

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments

Trond Riise, Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Elisabeth Gulowsen Celius, Rune Midgard, Jan Harald Aarseth
2013

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction

Rune Midgard, Øivind Torkildsen, Trygve Holmøy, Kjell-Morten Myhr, Stig Wergeland
2013-09-19

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

Pål Aukrust, Thor Ueland, Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Annika E. Michelsen, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, Antonie G Beiske, Kristian S Bjerve, Harald Hovdal, Finn Lilleås, Rune Midgard, Stig Wergeland
2013-01-06

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway

Trygve Holmøy, Kjell-Morten Myhr, Espen Benjaminsen, Øivind Torkildsen, Elisabeth Gulowsen Celius, Rune Midgard, Jan Harald Aarseth
2012-05-09

Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population

Rune Midgard, Geir Bråthen, Nils Erik Gilhus, Hanne F Harbo, Benedicte A Lie
2012-08-01

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial

Kjell-Morten Myhr, Øivind Torkildsen, Rune Midgard, Stig Wergeland
2012-08-20

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.

Trygve Holmøy, Kjell-Morten Myhr, Øivind Torkildsen, Rune Midgard, Stig Wergeland
2012-12-20

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Trygve Holmøy, Kjell-Morten Myhr, Espen Benjaminsen, Øivind Torkildsen, Elisabeth Gulowsen Celius, Rune Midgard, Jan Harald Aarseth
2012-06-13

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment

Øivind Torkildsen, Kjell-Morten Myhr, Trygve Holmøy, Rune Midgard, Stig Wergeland
2012-07-17

Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients

Trygve Holmøy, Rune Midgard, Kjell-Morten Myhr
2011-02-22

Risk of MS is not associated with exposure to crude oil, but increases with low level of education.

Trond Riise, Elisabeth Farbu, Kjell-Morten Myhr, Åse Mygland, Rune Midgard, Jan Harald Aarseth
2010-12-10

Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway

Kjell-Morten Myhr, Rune Midgard, Jan Harald Aarseth
2009-01-29

Early prognostic factors for disability in multiple sclerosis, a European multicenter study

Trond Riise, Johan Arild Aarli, Rune Midgard
2008-06-21

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

Tone Skarpaas, Unn Ljøstad, Åse Mygland, Randi Eikeland, Rune Midgard

Human - wd:Q59679941

Welcome to Inventaire

the library of your friends and communities

learn more